A new study has revealed the discovery of a novel oncogene that is associated with uveal melanoma, the most common form of eye cancer.
Laser system shows promise for cataract surgery
A new system for femtosecond laser-assisted cataract surgery is not only safe but also cuts circles in lens capsules that are 12 times more precise than those achieved by the traditional method, as well as leaving edges that are twice…
VisionCare’s Macular Degeneration Telescope Implant Named ‘Best Of What’s New’ 2010 By Popular Science
VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices, today announced the Implantable Miniature Telescope (by Dr. Isaac Lipshitz), designed to improve vision in patients with end-stage age-related macular degenera…
VisionCare’s Macular Degeneration Telescope Implant Named ‘Best Of What’s New’ 2010 By Popular Science
VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices, today announced the Implantable Miniature Telescope (by Dr. Isaac Lipshitz), designed to improve vision in patients with end-stage age-related macular degenera…
Fluorescein Angiography, OCT Measurements Correlate With Visual Acuity In Eyes With DME
Fluorescein angiography, optical coherence tomography and color fundus photography showed similar associations with visual acuity in eyes treated for diabetic macular edema, a study found.
ISTA Pharmaceuticals Granted Three-Year Market Exclusivity For BROMDAY(TM)
ISTA Pharmaceuticals, Inc. , today announced the U.S. Food and Drug Administration (FDA) has granted the Company three years of marketing exclusivity for BROMDAY(TM) (bromfenac ophthalmic solution) 0.09%, as provided under the Drug Price Competition an…